141 related articles for article (PubMed ID: 35700821)
1. Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma.
Jiang Q; Mao H; He G; Mao X
Cancer Lett; 2022 Sep; 543():215791. PubMed ID: 35700821
[TBL] [Abstract][Full Text] [Related]
2. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
[TBL] [Abstract][Full Text] [Related]
3. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
Hurt EM; Wiestner A; Rosenwald A; Shaffer AL; Campo E; Grogan T; Bergsagel PL; Kuehl WM; Staudt LM
Cancer Cell; 2004 Feb; 5(2):191-9. PubMed ID: 14998494
[TBL] [Abstract][Full Text] [Related]
5. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.
Xu Y; Sun T; Zeng K; Xu M; Chen J; Xu X; Zhang Z; Cao B; Tang X; Wu D; Kong Y; Zeng Y; Mao X
Cell Death Dis; 2020 Sep; 11(9):818. PubMed ID: 32999280
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.
Sun T; Xu Y; Xu Z; Cao B; Zhang Z; Wang Q; Kong Y; Mao X
Cell Commun Signal; 2021 Feb; 19(1):24. PubMed ID: 33627137
[TBL] [Abstract][Full Text] [Related]
7. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
[TBL] [Abstract][Full Text] [Related]
9. A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).
Morito N; Yoh K; Maeda A; Nakano T; Fujita A; Kusakabe M; Hamada M; Kudo T; Yamagata K; Takahashi S
Cancer Res; 2011 Jan; 71(2):339-48. PubMed ID: 21224354
[TBL] [Abstract][Full Text] [Related]
10. MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.
Katsarou A; Trasanidis N; Ponnusamy K; Kostopoulos IV; Alvarez-Benayas J; Papaleonidopoulou F; Keren K; Sabbattini PMR; Feldhahn N; Papaioannou M; Hatjiharissi E; Sudbery IM; Chaidos A; Caputo VS; Karadimitris A
Blood Adv; 2023 Nov; 7(21):6395-6410. PubMed ID: 37224458
[TBL] [Abstract][Full Text] [Related]
11. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
[TBL] [Abstract][Full Text] [Related]
16. Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism.
von Scheidt M; Zhao Y; de Aguiar Vallim TQ; Che N; Wierer M; Seldin MM; Franzén O; Kurt Z; Pang S; Bongiovanni D; Yamamoto M; Edwards PA; Ruusalepp A; Kovacic JC; Mann M; Björkegren JLM; Lusis AJ; Yang X; Schunkert H
Circulation; 2021 May; 143(18):1809-1823. PubMed ID: 33626882
[TBL] [Abstract][Full Text] [Related]
17. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.
Tai YT; Soydan E; Song W; Fulciniti M; Kim K; Hong F; Li XF; Burger P; Rumizen MJ; Nahar S; Podar K; Hideshima T; Munshi NC; Tonon G; Carrasco RD; Afar DE; Anderson KC
Blood; 2009 Apr; 113(18):4309-18. PubMed ID: 19196658
[TBL] [Abstract][Full Text] [Related]
18. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
[TBL] [Abstract][Full Text] [Related]
19. Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
Li H; Zhu X; Sun Z; Wang Q; Song S; Xu Y; He G; Mao X
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):176-185. PubMed ID: 38230274
[TBL] [Abstract][Full Text] [Related]
20. Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Natkunam Y; Tedoldi S; Paterson JC; Zhao S; Rodriguez-Justo M; Beck AH; Siebert R; Mason DY; Marafioti T
Am J Clin Pathol; 2009 Sep; 132(3):361-71. PubMed ID: 19687312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]